[1] CHEN L, QU H, GUO M, et al. ANRIL and atherosclerosis[J]. J Clin Pharm Ther, 2020, 45(2): 240-248.
[2] HU Y, HU J. Diagnostic value of circulating lncRNA ANRIL and its correlation with coronary artery disease parameters[J]. Braz J Med Biol Res, 2019, 52(8): e8309.
[3] GHAFOURI-FARD S, GHOLIPOUR M, TAHERI M. The emerging role of long non-coding RNAs and circular RNAs in coronary artery disease[J]. Front Cardiovasc Med, 2021, 8: 632393.
[4] XIE Y, ZHAO D, DONG P, et al. Effects of ANRIL polymorphisms on the likelihood of coronary artery disease: a meta-analysis[J]. J Cell Biochem, 2019, 120(4): 6113-6119.
[5] BAI Y, NIE S, JIANG G, et al. Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke[J]. Stroke, 2014, 45(2): 383-388.
[6] ZHOU X, HAN X, WITTFELDT A, et al. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-kappaB pathway[J]. RNA Biol, 2016, 13(1): 98-108.
[7] ZHANG B, WANG D, JI T F, et al. Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-kappaB signaling pathway in a rat model[J]. Oncotarget, 2017, 8(10): 17347-17359.
[8] MCARTHUR K, FENG B, WU Y, et al. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy[J]. Diabetes, 2011, 60(4): 1314-1323.
[9] LINDER A, BAUERNFRIED S, CHENG Y, et al. CARD8 inflammasome activation triggers pyroptosis in human T cells[J]. EMBO J, 2020, 39(19): e105071.
[10] YE S, ZHU S, FENG L. LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma[J]. J Clin Lab Anal, 2020, 34(3): e23092.
[11] SONG C L, WANG J P, XUE X, et al. Effect of circular ANRIL on the inflammatory response of vascular endothelial cells in a rat model of coronary atherosclerosis[J]. Cell Physiol Biochem, 2017, 42(3): 1202-1212.
[12] ZHANG C, GE S, GONG W, et al. LncRNA ANRIL acts as a modular scaffold of WDR5 and HDAC3 complexes and promotes alteration of the vascular smooth muscle cell phenotype[J]. Cell Death Dis, 2020, 11(6): 435.
[13] KOTAKE Y, NAKAGAWA T, KITAGAWA K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene[J]. Oncogene, 2011, 30(16): 1956-1962.
[14] CONGRAINS A, KAMIDE K, KATSUYA T, et al. CVD-associated non-coding RNA, ANRIL, modulates expression of atherogenic pathways in VSMC[J]. Biochem Biophys Res Commun, 2012, 419(4): 612-616.
[15] TAN P, GUO Y H, ZHAN J K, et al. LncRNA-ANRIL inhibits cell senescence of vascular smooth muscle cells by regulating miR-181a/Sirt1[J]. Biochem Cell Biol, 2019, 97(5): 571-580.
[16] GUO F, TANG C, LI Y, et al. The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-kappaB signalling pathway[J]. J Cell Mol Med, 2018, 22(10): 5062-5075.
[17] GRAY K, KUMAR S, FIGG N, et al. Effects of DNA damage in smooth muscle cells in atherosclerosis[J]. Circ Res, 2015, 116(5): 816-826.
[18] NAEMURA M, TSUNODA T, INOUE Y, et al. ANRIL regulates the proliferation of human colorectal cancer cells in both two- and three-dimensional culture[J]. Mol Cell Biochem, 2016, 412(1/2): 141-146.
[19] PATEL S, WILKINSON C J, SVIDERSKAYA E V. Loss of both CDKN2A and CDKN2B allows for centrosome overduplication in melanoma[J]. J Invest Dermatol, 2020, 140(9): 1837-1846.
[20] ZENG R, SONG X J, LIU C W, et al. LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway[J]. Am J Transl Res, 2019, 11(12): 7441-7448.
[21] CHAI L, YUAN Y, CHEN C, et al. The role of long non-coding RNA ANRIL in the carcinogenesis of oral cancer by targeting miR-125a[J]. Biomed Pharmacother, 2018, 103: 38-45.
[22] BOCHENEK G, HASLER R, EL M N, et al. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10[J]. Hum Mol Genet, 2013, 22(22): 4516-4527.
[23] SUN L Y, LI X J, SUN Y M, et al. LncRNA ANRIL regulates AML development through modulating the glucose metabolism pathway of AdipoR1/AMPK/SIRT1[J]. Mol Cancer, 2018, 17(1): 127.
[24] AGUILAR V, FAJAS L. Cycling through metabolism[J]. EMBO Mol Med, 2010, 2(9): 338-348.
[25] LAGARRIGUE S, LOPEZ-MEJIA I C, DENECHAUD P D, et al. CDK4 is an essential insulin effector in adipocytes[J]. J Clin Invest, 2016, 126(1): 335-348.
[26] KONG Y, SHARMA R B, LY S, et al. CDKN2A/B T2D genome-wide association study risk SNPs impact locus gene expression and proliferation in human islets[J]. Diabetes, 2018, 67(5): 872-884.
[27] HOLDT L M, STAHRINGER A, SASS K, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans[J]. Nat Commun, 2016, 7: 12429.
[28] FANG J, PAN Z, WANG D, et al. Multiple non-coding ANRIL transcripts are associated with risk of coronary artery disease: a promising circulating biomarker[J]. J Cardiovasc Transl Res, 2021, 14(2): 229-237.
[29] KAUR N, SINGH J, REDDY S. ANRIL rs1333049 C/G polymorphism and coronary artery disease in a North Indian population-Gender and age specific associations[J]. Genet Mol Biol, 2020, 43(1): e20190024.
[30] YAGHOUBI H F, SALAHSHOURIFAR I, ZARE K S. Association between coronary artery disease and rs10757278 and rs1333049 polymorphisms in 9p21 locus in Iran[J]. Rep Biochem Mol Biol, 2020, 9(1): 58-63.
[31] YANG J, GU L, GUO X, et al. LncRNA ANRIL expression and ANRIL gene polymorphisms contribute to the risk of ischemic stroke in the Chinese Han population[J]. Cell Mol Neurobiol, 2018, 38(6): 1253-1269.
[32] CHENG J, CAI M Y, CHEN Y N, et al. Variants in ANRIL gene correlated with its expression contribute to myocardial infarction risk[J]. Oncotarget, 2017, 8(8): 12607-12619.
[33] VAUSORT M, WAGNER D R, DEVAUX Y. Long noncoding RNAs in patients with acute myocardial infarction[J]. Circ Res, 2014, 115(7): 668-677.
[34] ZHUANG J, PENG W, LI H, et al. Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease[J]. PLoS One, 2012, 7(10): e47193.
[35] YANG J, HUANG X, HU F, et al. LncRNA ANRIL knockdown relieves myocardial cell apoptosis in acute myocardial infarction by regulating IL-33/ST2[J]. Cell Cycle, 2019, 18(23): 3393-3403.
[36] HUANG Q, PAN M, ZHOU J P, et al. Overexpression of long non-coding RNA ANRIL promotes post-ischaemic angiogenesis and improves cardiac functions by targeting Akt[J]. J Cell Mol Med, 2020, 24(12): 6860-6868.
[37] HU D J, LI Z Y, ZHU Y T, et al. Overexpression of long noncoding RNA ANRIL inhibits phenotypic switching of vascular smooth muscle cells to prevent atherosclerotic plaque development in vivo[J]. Aging: Albany NY, 2020, 13(3): 4299-4316.
[38] SHI P, JI H, ZHANG H, et al. circANRIL reduces vascular endothelial injury, oxidative stress and inflammation in rats with coronary atherosclerosis[J]. Exp Ther Med, 2020, 20(3): 2245-2251.
[39] DAI W, LEE D. Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress[J]. J Cell Biochem, 2019, 120(10): 18446-18456. |
